BUSINESS

• Heptares, Kymab Tie Up for Joint Research on Cancer Immunotherapy
  April 19, 2016

• Wholesalers Say Drug Distributions in Quake-Hit Kumamoto More or Less Stable
  April 19, 2016

• Sanwa Kagaku’s Kumamoto Factory Shuts Down after Quake
  April 18, 2016

• Kaketsuken Halts Operations on April 18-20 after Quake
  April 18, 2016

• Announcement: 9th Annual eyeforpharma Japan 2016 - Westin Tokyo, July 13-14
  April 15, 2016

• Sumitomo Dainippon, Kyoto Univ. Extend Cancer Research Collaboration
  April 12, 2016

• MSD Picks Taiho as Copromotion Partner for Pembrolizumab
  April 12, 2016

• Ono Fires Back to 1.75 Trillion Yen Guesstimate, Puts Opdivo Sales at 126 Billion Yen
  April 12, 2016

• AC Medical to Introduce 3rd-Party Review Service for Advertising, Promotional Materials
  April 12, 2016

• Companion Diagnostic for Tagrisso Now Covered by Health Insurance
  April 11, 2016

• Ethical Drug Sales Jump 15.6% in February: Crecon Report
  April 11, 2016

• Ex-Genzyme Japan Chief Hideyuki Ashikaga to Lead Baxter Japan
  April 11, 2016

• Astellas Introduces 1st Major Reform of Domestic Marketing System in 10 Years to Understand Issues Specific to Each Area: Marketing Head
  April 8, 2016

• Kaketsuken in Talks to Transfer Vaccine Biz to Astellas
  April 8, 2016

• Bayer Japan Taps Big Data to Shorten Trial Site Selection by 1-2 Months; 2015 Sales Up 12.2%
  April 7, 2016

• Takecab Most Promoted Drug in February: Anterio
  April 7, 2016

• Terumo Preparing to Launch HeartSheet; Sees Room for Improvements in Production and Quality Control
  April 7, 2016

• MSD, Alfresa, Aerosense to Collaborate in Developing a Drug Delivery Business Using Drones
  April 7, 2016

• Mylan Japan Labor Union Raps Management over “Effective Dismissal”, No Progress Made in 1st Round of Negotiations
  April 6, 2016

• Daiichi Sankyo Joins Portola’s Factor Xa Antidote Consortium in Japan
  April 6, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 463
• 464
• 465
• 466
• 467
• 468
• 469
• 470
• 471
• …
• Next ›
• 最終 »